盟科药业-U
(688373)
| 流通市值：21.79亿 | | | 总市值：39.05亿 |
| 流通股本：3.66亿 | | | 总股本：6.55亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 386,262,631.61 | 254,014,785.61 | 148,462,125.93 | 217,331,337.67 |
| 应收票据及应收账款 | 31,878,371.44 | 30,597,934.17 | 23,753,117.18 | 26,359,705.02 |
| 应收账款 | 31,878,371.44 | 30,597,934.17 | 23,753,117.18 | 26,359,705.02 |
| 预付款项 | 18,737,536.57 | 33,267,259.22 | 30,518,666.74 | 40,333,416.78 |
| 其他应收款合计 | 21,019,751.21 | 213,329.1 | 306,413.6 | 410,921.33 |
| 存货 | 52,936,424 | 45,452,339.78 | 42,589,170.63 | 34,878,527.91 |
| 其他流动资产 | 30,470,693.12 | 19,364,289.24 | 22,327,038.09 | 11,113,419.58 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 748,661,957.2 | 869,192,299.77 | 896,380,052.57 | 992,871,282.96 |
| 非流动资产: | | | | |
| 固定资产 | 5,824,313.36 | 6,314,160.63 | 6,797,410.85 | 6,971,598.41 |
| 使用权资产 | 69,974,353.53 | 69,779,846.71 | 73,277,083.57 | 75,915,632.04 |
| 无形资产 | 1,680,076.79 | 1,760,954.87 | 1,809,254.39 | 1,937,535.73 |
| 长期待摊费用 | 19,099,135.89 | 19,502,883.76 | 20,096,541.27 | 20,999,909.32 |
| 其他非流动资产 | 3,888,822.85 | 4,199,470.25 | 4,489,894.91 | 4,489,036.08 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 100,466,702.42 | 101,557,316.22 | 106,470,184.99 | 110,313,711.58 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 849,128,659.62 | 970,749,615.99 | 1,002,850,237.56 | 1,103,184,994.54 |
| 流动负债: | | | | |
| 短期借款 | 5,000,000 | - | - | - |
| 应付票据及应付账款 | 74,776,456.31 | 73,075,444.47 | 59,339,424.55 | 84,089,468.45 |
| 应付账款 | 74,776,456.31 | 73,075,444.47 | 59,339,424.55 | 84,089,468.45 |
| 应付职工薪酬 | 12,190,904.75 | 12,368,608.19 | 8,840,092.31 | 9,677,170.34 |
| 应交税费 | 10,200,093.95 | 1,366,431.26 | 902,633.99 | 6,190,567.12 |
| 其他应付款合计 | 9,387,188.2 | 10,542,316.23 | 8,425,326.41 | 13,141,944.04 |
| 一年内到期的非流动负债 | 100,741,940.01 | 30,674,626.71 | 30,914,374.09 | 24,876,481.86 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 212,296,583.22 | 128,027,426.86 | 108,421,851.35 | 137,975,631.81 |
| 非流动负债: | | | | |
| 长期借款 | 122,940,000 | 198,450,000 | 161,950,000 | 142,960,000 |
| 租赁负债 | 73,178,324.69 | 74,868,895.66 | 76,450,368.3 | 79,039,200.35 |
| 递延收益 | 1,750,000 | 1,750,000 | 1,400,000 | 1,400,000 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 197,868,324.69 | 275,068,895.66 | 239,800,368.3 | 223,399,200.35 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 410,164,907.91 | 403,096,322.52 | 348,222,219.65 | 361,374,832.16 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 655,605,491 | 655,210,084 | 655,210,084 | 655,210,084 |
| 资本公积 | 1,570,967,921.81 | 1,555,179,684.7 | 1,549,487,186.77 | 1,541,126,617.41 |
| 其他综合收益 | 17,081,837.14 | 12,529,951.91 | 15,205,275.1 | 11,580,365.79 |
| 未分配利润 | -1,804,691,498.24 | -1,655,266,427.14 | -1,565,274,527.96 | -1,466,106,904.82 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 438,963,751.71 | 567,653,293.47 | 654,628,017.91 | 741,810,162.38 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 438,963,751.71 | 567,653,293.47 | 654,628,017.91 | 741,810,162.38 |
| 负债和股东权益合计 | 849,128,659.62 | 970,749,615.99 | 1,002,850,237.56 | 1,103,184,994.54 |
| 公告日期 | 2025-03-18 | 2024-10-25 | 2024-08-29 | 2024-04-26 |
| 审计意见(境内) | 标准无保留意见 | | | |